Zydus’ poor cholesterol medication receives Phase I trial approval from Central Drugs Standard Control Organization. [Representational image only Credit : Unsplash/] Courtesy : TH ; 29/09/2023
Sun. Oct 11th, 2026
Zydus’ poor cholesterol medication receives Phase I trial approval from Central Drugs Standard Control Organization. [Representational image only Credit : Unsplash/] Courtesy : TH ; 29/09/2023